Daisuke Tomita

Dr. Daisuke Tomita

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2024 in Cureus
Verified
Journal Article
Open access
DTDaisuke Tomita
Daisuke Tomita
KFKentoku Fujisawa
Kentoku Fujisawa
YOYu Ohkura
Yu Ohkura
MUMasaki Ueno
Masaki Ueno
HUHarushi Udagawa
Harushi Udagawa
Esophagectomy is the standard treatment for esophageal cancer and often involves the stomach as asubstitute organ for esophageal reconstruction. However, we actively perform stomach-preserved ileocolicinterposition because of its advantages in gastrointestinal function and the prevention of reflux esophagitis.Despite its benefits, few facilities perform esophageal reconstruction with ileocolic interposition; hence,postoperative complications following this procedure have rarely been reported. We present the first case ofinternal hernia through a mesenteric defect following esophagectomy and reconstruction with a stomach-preserved ileocolic interposition. This type of internal hernia after esophageal cancer surgery is a rarecomplication following a common gastric pull-up reconstruction.A 66-year-old Japanese female underwent esophagectomy and reconstruction with stomach-preservedileocolic interposition for stage I esophageal cancer. One month after surgery, the patient experiencedabdominal pain and vomiting. CT showed a dilated small bowel and a suspected postoperative adhesivebowel obstruction. Despite conservative management, the patient experienced recurrent episodes thatrequired hospitalization. Although an exact preoperative diagnosis was not made, we decided on a surgicalexploration six months after the first symptoms appeared. Laparotomy revealed an internal herniationthrough a mesenteric defect between the transverse mesocolon and the ileum mesentery following ileocolicinterposition. We then repositioned the fitted small intestine and closed the mesenteric defects. The patientrecovered uneventfully without a hernia recurrence.Minimally invasive techniques for treating esophageal cancer are becoming more common. As survival ratesimprove, the number of internal hernia cases, such as those described in this report, will likely increase.Therefore, more cases are needed to determine whether closing mesenteric defects can effectively preventherniation. However, immediate surgical treatment should be considered based on the symptoms, evenwhen a preoperative diagnosis is difficult

18 April 2024 in Cureus
Verified
Journal Article
Open access
PDF file
DTDaisuke Tomita
Daisuke Tomita
STShigeo Toda
Shigeo Toda
RMRyo Miyazaki
Ryo Miyazaki
SMShuichiro Matoba
Shuichiro Matoba
HKHiroya Kuroyanagi
Hiroya Kuroyanagi
Intramural intestinal hematoma is a rare disease, one of the triggering factors of which is the use of anticoagulants. In previous reports, most patients were on treatment with warfarin. Herein, we report a case of direct-acting oral anticoagulant (DOAC)-induced intramural hematoma of the ascending colon in a patient refractory to conservative treatment and required laparoscopic right hemicolectomy. An 80-year-old male patient with a history of atrial fibrillation and cerebral infarction, on treatment with apixaban, was brought to our hospital with the chief complaints of abdominal pain, vomiting, and melena. Imaging revealed the cause of symptoms to be intestinal obstruction caused by a mass lesion on the wall of the ascending colon. We initially opted for conservative treatment with discontinuation of apixaban and insertion of an ileus tube. Intestinal dilatation findings showed improvement; however, subsequent imaging examinations did not reveal the shrinkage of a lesion in the ascending colon. If the mass was not removed, recurrence of bowel obstruction symptoms was expected, so we decided to perform surgical intervention. A laparoscopic right hemicolectomy was performed, and an intramural hematoma of the ascending colon was diagnosed based on the excised specimen. He needed a blood transfusion for anemia but was discharged on postoperative day 14 with no other complications. DOACs are now widely used in patients with atrial fibrillation, and the risk of bleeding as a side effect is extremely low compared to conventional anticoagulants, including warfarin. However, when abdominal pain occurs, as in the present case, an intramural hematoma should be considered in the differential diagnosis. There is no established treatment plan for intestinal intramural hematoma. Although conservative treatment is effective in some cases, it is difficult to evaluate the risk of bleeding associated with DOACs using coagulation tests. Even if conservative treatment is selected, it is essential to determine surgical resection, if necessary, based on the clinical course and imaging and blood test findings.

15 March 2024 in Cureus
Verified
Journal Article
Open access
DTDaisuke Tomita
Daisuke Tomita
KNKodai Nagakari
Kodai Nagakari
YFYudai Fukui
Yudai Fukui
KIKo Ichimori
Ko Ichimori
HKHiroya Kuroyanagi
Hiroya Kuroyanagi
The development of transplantation technology has improved the prognosis of transplantation surgery; however, the negative impact of immunosuppressive drugs has increased the number of patients with cancer after transplantation. Recently, minimally invasive surgery has become more common for cancer treatment. We report our experience of performing laparoscopic sigmoid colon resection for a patient with a history of two renal transplantations and peritoneal dialysis. A 42-year-old male patient who developed purpura nephropathy underwent renal transplantation at ages eight and 34 years. He had been on peritoneal dialysis for five years before the second transplantation. The patient was referred to our department with the chief complaint of sudden abdominal pain. After an examination of imaging, we obtained a diagnosis of sigmoid colon cancer. Despite a history of peritoneal dialysis, laparoscopic sigmoid colon resection was successfully performed without complications after confirming that there were no adhesions in the abdominal cavity. The left lower port position had to be adjusted because the transplanted kidney protruded into the left iliac fossa. No postoperative complications and graft loss occurred. In this case, laparoscopic surgery was effective in lowering the risk of damage to the transplanted kidney and safely performing the procedure. The number of colorectal cancer cases in renal transplant patients is expected to increase, and some of these patients will have a history of peritoneal dialysis, which may make surgery more difficult. The successful outcome of this case highlights that laparoscopic surgery could be viable for patients with such a complex medical history.

15 August 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
KHKosuke Hiramatsu
Kosuke Hiramatsu
STShigeo Toda
Shigeo Toda
SMShuichiro Matoba
Shuichiro Matoba
DTDaisuke Tomita
Daisuke Tomita
YMYusuke Maeda
Yusuke Maeda
HKHiroya Kuroyanagi
Hiroya Kuroyanagi
Total pelvic exenteration (TPE) is a radical surgical procedure indicated for advanced pelvic malignancies involving adjacent organs. The Hugo™ RAS system, a newly introduced alternative to existing robotic platforms, has not yet been reported for use in TPE for rectal cancer. We present the first known case of robotic-assisted TPE using the Hugo™ RAS system in a patient with locally advanced rectal cancer (LARC) invading the prostate. A 69-year-old male presented with mucous and bloody stools and was diagnosed with cT4b (prostate, levator ani muscle) N0M0 rectal cancer. Following neoadjuvant short-course radiotherapy (25 Gy in 5 fractions), robotic-assisted TPE was performed. Port placement was strategically modified to overlap with the planned colostomy and urostomy sites, minimizing abdominal wall trauma. Radical en bloc resection was performed, and pelvic reconstruction was achieved using a gluteus maximus musculocutaneous flap combined with a fascia lata autograft. Urinary reconstruction was achieved with a robotic intracorporeal Wallace-type ileal conduit. The total operative time was 17 hours and 56 minutes, with an estimated blood loss of 175 mL. The postoperative course was complicated by Clavien–Dindo grade Ⅲa paralytic ileus, which resolved with conservative management. The final pathology showed pT4b (prostate) N1a M0 disease with a negative circumferential resection margin (11 mm). At 9-month follow-up, no recurrence was observed. This case demonstrates the technical feasibility and safety of robotic-assisted TPE using the Hugo™ RAS system. Further clinical experience and long-term follow-up are necessary to establish its reproducibility and oncologic safety.

11 February 2025 in Colorectal Disease
Verified
Journal Article
Closed access
DTDaisuke Tomita
Daisuke Tomita
YHYutaka Hanaoka
Yutaka Hanaoka
JKJumpei Kashiwagi
Jumpei Kashiwagi
YTYasuhiro Takahashi
Yasuhiro Takahashi
SMShuichiro Matoba
Shuichiro Matoba
HKHiroya Kuroyanagi
Hiroya Kuroyanagi

21 September 2026 in Frontiers in Surgery
Verified
Journal Article
Open access
PDF file
DTDaisuke Tomita
Daisuke Tomita
STShigeo Toda
Shigeo Toda
SMShuichiro Matoba
Shuichiro Matoba
YMYusuke Maeda
Yusuke Maeda
YKYasutaka Kuno
Yasutaka Kuno
HKHiroya Kuroyanagi
Hiroya Kuroyanagi
Radical resection is essential for achieving R0 resection and improving prognosis in patients with locally advanced colorectal cancer (CRC) involving adjacent organs. When combined ureteral resection is required, urinary tract reconstruction is critical, as it influences both the risk of complications and postoperative quality of life. Here, we report three cases of locally advanced CRC with suspected ureteral invasion, treated with neoadjuvant chemotherapy (NAC) followed by laparoscopic tumor resection and ureteral reconstruction using the psoas hitch technique, which avoids the use of intestinal segments. Three patients with locally advanced CRC and suspected ureteral involvement received six cycles of FOLFOXIRI-based neoadjuvant chemotherapy (with panitumumab added in one patient). After significant tumor shrinkage, laparoscopic radical resection, including combined ureteral resection, was performed. Ureteroneocystostomy was carried out under direct vision through a lower transverse (Pfannenstiel) incision. Operative times ranged from 505 to 727 min, with no major complications. Postoperative histopathology revealed ypT3N0M0, ypT3N1aM0, and ypT4bN1bM0, respectively, with no pathological evidence of ureteral invasion. All patients received adjuvant chemotherapy and remain recurrence-free to date. Renal function was preserved postoperatively in all cases. We describe three cases in which neoadjuvant chemotherapy effectively shrank locally advanced CRC, yet combined ureteral resection was still necessary to ensure a secure R0 resection. Our approach enabled curative resection while preserving renal function and allowing for the timely initiation of adjuvant chemotherapy. When appropriate cases are selected, the psoas hitch technique can be a feasible and safe method for ureteral reconstruction.